Table 2.
2‐a | ||||
---|---|---|---|---|
Mutated | Gene | Left‐sided MSS CRCs (%) | Right‐sided MSS CRCs (%) | p‐values |
Total | 56 | 15 | ||
TP53 | positive | 33 (58.9) | 3 (20.0) | 0.006 |
KRAS | positive | 16 (28.6) | 11 (73.3) | 0.001 |
BRAF | positive | 1 (1.8) | 0 | NS |
PIK3CA | positive | 5 (8.9) | 1 (6.7) | NS |
Chi‐square test |
2‐b | ||||
---|---|---|---|---|
Left‐sided MSS CRCs (%) | Right‐sided MSS CRCs (%) | p‐values | ||
Total | 56 | 15 | ||
HME | 3 (5.3) | 0 | NS | |
IME | 28 (50.0) | 11 (73.3) | ||
LME | 25 (44.7) | 4 (26.7) | ||
Chi‐square test |
Abbreviations: CRCs: colorectal cancers; HME: high méthylation phenotype; IME: intermediate methylation phenotype; LME: low methylation phenotype.